Compression

Keep patient's blood flowing, which helps prevent blood clots and deep vein thrombosis (DVT)

Cordless

A rechargeable battery, with approximately 10 hours of use, ensures a full therapy session

Recovery

 Provides convenient in-home therapy for the recovery process

Surgeons partner with CureTech to reduce these statistics

Every 6 minutes

One person dies of a blood clot every six minutes.

6 in 10 Patients

6 in 10 patients experience VTE cases up to 90 days after surgery.

274 Deaths

On average, 274 people die everyday from blood clots.

Open your eyes to Venous Thromboembolism (VTE) & Prevention

Venous thromboembolism (VTE) is a condition in which a blood clot forms, most often in the deep veins of the leg, groin, or arm (known as deep vein thrombosis, DVT), and travels in the circulation before lodging in the lungs (known as pulmonary embolism, PE). Together, DVT and PE are known as VTE — a dangerous, potentially deadly medical condition. Your doctor will likely prescribe a program to help prevent DVT after your surgery, including medication and/or a PlasmaFlow Compression device, which helps promote blood flow back to the heart and prevent blood pooling.

In the U.S. and Europe, VTE-related events kill more people than AIDS, breast cancer, prostate cancer, and motor vehicle crashes combined.

Risk Factors

VTE does not discriminate. It affects people of all ages, races, and ethnicities, and occurring in both men and women. Certain factors and situations can increase the risk of developing potentially deadly blood clots.

High-Risk

  • Being in the hospital for an extended period of time
  • Having surgery (especially hip, knee, and cancer-related surgery)
  • Cancer patients, who have a 4x higher risk of developing a serious blood clot than the general population
  • Not moving for long periods of time (e.g. bedrest or long-duration travel)

Moderate Risk

  • Age (60+)
  • If you have a personal or family history of blood clots or have suffered a recent stroke
  • If you have experienced cancer or have gone through chemotherapy
  • If you have experienced any physical or mental trauma
  • If you have taken estrogen-based medication (e.g. oral contraceptives or hormone replacement therapy)

Other Factors

  • Major Surgery > 3 hours
  • Asthma / Lung disorder
  • Obesity
  • Pregnancy or recent birth
  • Diabetes
  • Spinal cord injury
  • Smoking
  • Alcohol consumption
  • Revision surgery

ManaMed PlasmaFlow

DVT Prevention using Sequential Compression

A Global Leader in DVT Prevention

Why leading physicians prescribe PlasmaFlow

 Helps prevent the onset of DVT
 Provides convenient in-home therapy
 Provides an alternative to anticoagulants
 Improves the patient experience
 Lowers total cost
Shop Online

The Advantages of PlasmaFlow

 Portable, lightweight, & tubeless
 User-friendly
Rechargeable Battery with up to 10 hours of use
 2 LCD screens to monitor usage & pressure
Shop Online

Product Details

PlasmaFlow helps PREVENT the onset of DVT with convenient home therapy. It offers best-in-class battery life, LCD displays to monitor pressure, and complete portability—no tubes, cords, or hoses.

Easy 1-Button Operation

The unit can switch between two modes at the push of a button.

Visual Display

The display shows the hour time, mode, and pressure level.

Cordless

PlasmaFlow offers greater flexibility and portability while eliminating the risk of patient slip and fall accidents.

Reduces Readmissions

PlasmaFlow helps prevent DVT, a leading factor for hospital readmissions following major orthopedic surgery.

Best-in-Class Battery Life

PlasmaFlow has up to 10 hours of battery life on just one charge.

Recharge Warning

The unit has a recharge warning, which is indicated by a blue light above the power button that becomes red when a charge is needed.

Hoop & Loop Fasteners

The unit has straps that adjust quickly and securely over the leg for a custom fit.

ManaMed PlasmaFlow

PlasmaFlow Instructions

View Gallery

Next slide arrow

Your Quicker Path to Recovery

Get back to doing
what you love.